Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference29 articles.
1. Multiple myeloma;Kyle;Blood.,2008
2. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling;Stewart;J Clin Oncol.,2005
3. Multiple myeloma;Dalton;Hematology Am Soc Hematol Educ Program.,2001
4. DNA methylation profiles of lymphoid and hematopoietic malignancies;Takahashi;Clin Cancer Res.,2004
5. DNA methylation changes in multiple myeloma;Galm;Leukemia.,2004
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HDAC inhibitors: Promising agents for leukemia treatment;Biochemical and Biophysical Research Communications;2023-11
2. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?;Pathology - Research and Practice;2023-08
3. Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase;Blood Advances;2023-03-20
4. Characterizing the Spectrum of Epigenetic Dysregulation Across Lymphoid Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15
5. Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance;Nature Communications;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3